Ligand profile
372
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: VK055_2684 — ribosyldihydronicotinamide dehydrogenase (quinone)
Identifiers
Database identifiers and provenance.
- Ligand ID
372- PDB
4gr9- UniProt (similar protein)
P16083- Target protein
- VK055_2684
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 73.2
- −1 ≤ LogP ≤ 5 1.62
- MW ≤ 500 Da 243.3
- LogP ≤ 5 1.62
- H-bond donors ≤ 5 1
- H-bond acceptors ≤ 10 3
- Rotatable bonds ≤ 10 2
- TPSA ≤ 140 Ų 73.2
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CC(=O)Nc1ccc2c(c1)C(C(=O)N2C)CC#NCC(=O)Nc1ccc2c(c1)C(C(=O)N2C)CC#N
InChI=1S/C13H13N3O2/c1-8(17)15-9-3-4-12-11(7-9)10(5-6-14)13(18)16(12)2/h3-4,7,10H,5H2,1-2H3,(H,15,17)InChI=1S/C13H13N3O2/c1-8(17)15-9-3-4-12-11(7-9)10(5-6-14)13(18)16(12)2/h3-4,7,10H,5H2,1-2H3,(H,15,17)
PFJVUECMVVMLTI-UHFFFAOYSA-NPFJVUECMVVMLTI-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF02525
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand 372 →
- PDB RCSB structure 4gr9 →
- UniProt UniProt P16083 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “372”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_2684.
PDB 59
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).